Related Experiment Videos
Src protein-tyrosine kinase structure and regulation
1Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, 1100 Florida Avenue, New Orleans, LA 70119, USA. biocrr@lsuhsc.edu
Biochemical and Biophysical Research Communications
|October 27, 2004
Summary
Src and Src-family kinases are crucial proto-oncogenes regulating cell functions. Their activity is controlled by phosphorylation, with C-terminal Src kinase (CSK) playing a key inhibitory role.
Area of Science:
- Molecular Biology
- Biochemistry
- Oncology
Background:
- Src and Src-family protein kinases are proto-oncogenes vital for cell morphology, motility, proliferation, and survival.
- v-Src (viral) and Src (cellular) are key players, with Src encoded by a physiological gene.
- Src structure includes an N-terminal myristoyl group, unique segment, SH3, SH2, kinase domains, and a C-terminal tail.
Purpose of the Study:
- To elucidate the structural and functional roles of Src and C-terminal Src kinase (CSK) in regulating kinase activity.
- To understand the mechanism of Src activation and inhibition, particularly the role of phosphorylation at Tyr416 and Tyr527.
- To investigate the structural differences between Src and CSK and their implications for enzyme conformation and substrate interaction.
Main Methods:
- Analysis of Src and CSK protein structures, including X-ray crystallography.
- Investigation of phosphorylation sites (Tyr416 and Tyr527) and their impact on Src activity.
- Study of protein-tyrosine phosphatases (e.g., PTPalpha) in mediating Src dephosphorylation and activation.
- Structural comparison of Src and CSK, focusing on SH2 and SH3 domain positioning and their effect on enzyme conformation.
Main Results:
- Src is activated by autophosphorylation at Tyr416 and inhibited by CSK phosphorylation at Tyr527.
- In its restrained state, Src's SH2 and SH3 domains stabilize a dormant conformation.
- CSK's structure differs significantly from Src, with its SH2 and SH3 domains stabilizing an active conformation.
- CSK possesses a docking site for its physiological substrate, Src, distinct from artificial substrates.
Conclusions:
- Src kinase activity is tightly regulated by phosphorylation, with CSK acting as a key inhibitor.
- Structural differences between Src and CSK dictate their distinct conformational states and regulatory mechanisms.
- Understanding these regulatory pathways is crucial for comprehending proto-oncogene function and developing targeted therapies.